Thursday, October 4, 2012

• Cleveland BioLabs and These 4 Stocks Announce Important FDA Updatesat Wall St. Cheat Sheet (Thu, Oct 4)

Wednesday, October 3, 2012

• As ArQule Investors Panic, Watch Exelixis Tooat Seeking Alpha (Wed, Oct 3)
• ArQule abandons trials of lung cancer drug, tivantinibat bizjournals.com (Wed, Oct 3)
• Healthcare Business Update: Merck Cancer Med Safe, Roche May Try Againat Wall St. Cheat Sheet (Wed, Oct 3)
• Zacks #1 Rank Additions for WednesdayZacks (Wed, Oct 3)

Tuesday, October 2, 2012

• Tim Participacoes Faces Investigation and 3 Stocks that Have Hit 52-Week Lowsat Wall St. Cheat Sheet (Tue, Oct 2)
• S&P 500 Erases Loss as Apple Recovery Overshadows Spainat Bloomberg (Tue, Oct 2)
• Dow Closes Lower; Nasdaq, S&P 500 Edge Upat TheStreet (Tue, Oct 2)
• Why ArQule Was Chopped In Halfat Motley Fool (Tue, Oct 2)
• ArQule Falls After Ending Cancer Drug Study: Boston Moverat Bloomberg (Tue, Oct 2)
• The Nasdaq Now: Sirius XM Hits New 52-Week Highat Minyanville (Tue, Oct 2)
• ArQule Plunges 50%, What's Next?at Motley Fool (Tue, Oct 2)
• ArQule stock plunges as lung cancer study shelvedAP (Tue, Oct 2)
• ArQule's Stock Tanks on Lung Cancer Drug Failureat Minyanville (Tue, Oct 2)
• Arqule Shutters Lung Cancer Study Early Due to Futilityat TheStreet (Tue, Oct 2)
• ARQULE INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Oct 2)

Thursday, September 27, 2012

• Aratana Therapeutics’ first CFO brings IPO experienceat bizjournals.com (Thu, Sep 27)

Thursday, September 13, 2012

• 7 Innovative Biotechs That Could Soar By Year-End: George Zavoicoat Seeking Alpha (Thu, Sep 13)

Wednesday, September 12, 2012

• LivePerson INITIATED at Buy and 4 Analyst-Initiated Shares on the Moveat Wall St. Cheat Sheet (Wed, Sep 12)

Thursday, August 30, 2012

• This Drug Is Getting Some Negative ATTENTIONat Motley Fool (Thu, Aug 30)
• Intel Is Likely to OUTPERFORM and 4 HOT Stock Analyses to Noteat Wall St. Cheat Sheet (Thu, Aug 30)
• Healthcare Business Recap: Lilly ABANDONS This Drug, ArQule Shares COLLAPSEat Wall St. Cheat Sheet (Thu, Aug 30)

Wednesday, August 29, 2012

• Why ArQule Shares Nosedivedat Motley Fool (Wed, Aug 29)
• ArQule plunges on delay in cancer drug studyAP (Wed, Aug 29)
• ArQule Shares Drop on Lung Cancer Drug Safety Concernat Minyanville (Wed, Aug 29)

Add ARQL News to My Yahoo!